Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The mutant HR bmh protein affects hair follicle formation by failing to repress vitamin D receptor activity.

A truncated protein linked to breast cancer may change cell adhesion.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

CAP1/Prss8 does not activate PAR2 or inhibit PN-1.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

New and known mutations in the hairless gene cause a hair loss condition called Atrichia with papular lesions.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

AQB reduces harmful skin changes in systemic sclerosis.

Keratin 17 is modified by RSK1 in response to growth and stress, affecting skin growth and stress response.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

The T allele of the PTPN22 gene may increase the risk of alopecia areata.

Higher levels of IL-1R1 and hsa-miR-19b-3p may help diagnose and predict alopecia areata severity.

The mutation causing Hutchinson-Gilford progeria syndrome leads to severe skin problems and early death in mice.

A new genetic mutation linked to Hutchinson-Gilford progeria syndrome was found in China.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

A genetic region near the PAX1 gene is linked to a higher risk of scoliosis in females.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Overexpression of hurpin in mice leads to abnormal skin and higher skin cancer risk.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

A specific gene change in APCDD1 increases the risk of hair loss.

Different STUB1 gene mutations cause varied symptoms in autosomal recessive ataxias.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

S100A6 protein is linked to disease progression, especially in cancers.

Certain proteins are significantly increased in the skin of people with hidradenitis suppurativa.

Heat Shock Proteins are important in the development of Polycystic Ovarian Syndrome and could be targets for new treatments.

SQSTM1 is linked to increased risk of alopecia areata.

A gene called APCDD1, which controls hair growth, is found to be faulty in a type of hair loss called hereditary hypotrichosis simplex.